- (0:30) - Upcoming Berkshire Hathaway Annual Meeting
- (7:15) - Buffett Beating Portfolio: 3 Tips
- (9:40) - Tracey’s Top Stock Picks
- (19:30) - Episode Roundup: OXY, APC, AVID, SNX, JCOM, BRKB
Welcome to Episode #139 of the Value Investor Podcast
Every week, Tracey Ryniec, the editor of Zacks Value Investor portfolio, shares some of her top value investing tips and stock picks.
This week is the Berkshire Hathaway annual meeting in Omaha.
Usually, it’s a lovefest between Warren Buffett and the thousands of shareholder-fans but Barron’s recently pointed out that Berkshire’s stock (BRK.B) has been under performing the S&P 500 for the last 5, 10 and 15 years.
Berkshire is also sitting on $110 billion in cash, which isn’t doing much for the stock either.
Just this week, it was revealed that Berkshire had pledged $10 billion in an investment for Occidental OXY to buy Anadarko APC, which is now the subject of a hostile bid with Chevron.
But the $10 billion is a drop in the cash bucket. What will they do with the other $100 billion?
All value investors are struggling in a market where growth stocks are king, but there are ways value investors can do better than Warren Buffett and his investing lieutenants.
3 Tips for Building a Better Portfolio
1. Think Small
Berkshire Hathaway is too big now. Buffett has billions to invest. He can’t mess around with a bunch of small cap companies.
But you can.
Avid Technology AVID is the platform that powers film, television and music. It has a market cap of just $319 million. It’s cheap, with a forward P/E of only 11.3.
2. Think Technology
Warren Buffett has mostly eschewed technology companies, with IBM and Apple being the exceptions.
But the rest of us shouldn’t.
There are plenty of technology stocks that are also values right now.
SYNNEX SNX is one of those. This technology services company has a price-to-sales ratio of just 0.3.
Shareholders also get a dividend, currently yielding 1.5%.
3. Think Digital
Warren Buffett has been a big fan of newspapers in the past, mostly for their amazing advertising moat in the classified ads.
But the Internet destroyed that moat and replaced it with digital media using display advertising.
Now, subscriptions are king and j2 Global JCOM is trying to get in on the changing digital media landscape. It operates a bunch of sites, including AskMen, Geek.com and Offers.com along with Everyday Health.
It is still cheap, with a forward P/E of just 12.9.
What else should you know about building a Buffett-beating portfolio?
Listen to this week’s episode to find out.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
j2 Global, Inc. (JCOM) : Free Stock Analysis Report
SYNNEX Corporation (SNX) : Free Stock Analysis Report
Avid Technology, Inc. (AVID) : Free Stock Analysis Report
Anadarko Petroleum Corporation (APC) : Free Stock Analysis Report
Occidental Petroleum Corporation (OXY) : Free Stock Analysis Report
To read this article on Zacks.com click here.